Overexpression of MTA1 inhibits the metastatic ability of ZR-75-30 cells in vitro by promoting MTA2 degradation

[1]  T. Voet,et al.  Identification of the tumour transition states occurring during EMT , 2018, Nature.

[2]  Chuanxin Wang,et al.  Overexpression of the metastasis‐associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma , 2017, Journal of gastroenterology and hepatology.

[3]  K. Hunt,et al.  Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence , 2014, Breast Cancer Research.

[4]  S. Hilsenbeck,et al.  Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer , 2013, Breast Cancer Research and Treatment.

[5]  Ying Xu,et al.  Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer , 2013, PloS one.

[6]  Yi Zheng,et al.  MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer. , 2013, Cancer research.

[7]  G. Mills,et al.  Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer , 2013, Breast Cancer Research.

[8]  Jun Qin,et al.  The MTA family proteins as novel histone H3 binding proteins , 2013, Cell & Bioscience.

[9]  Geoffrey I. Webb,et al.  PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites , 2012, PloS one.

[10]  Ana Lluch,et al.  Molecular biology in breast cancer: intrinsic subtypes and signaling pathways. , 2012, Cancer treatment reviews.

[11]  Ying Xu,et al.  Overexpression of TRIM24 Correlates with Tumor Progression in Non-Small Cell Lung Cancer , 2012, PloS one.

[12]  Ben Tran,et al.  Luminal-B breast cancer and novel therapeutic targets , 2011, Breast Cancer Research.

[13]  Valerie Speirs,et al.  Choosing the right cell line for breast cancer research , 2011, Breast Cancer Research.

[14]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[15]  J. Qin,et al.  The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis , 2011, Cell Research.

[16]  M. Horwitz,et al.  Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases , 2010, Pharmacological Reviews.

[17]  Anupama E. Gururaj,et al.  Acetylation‐dependent oncogenic activity of metastasis‐associated protein 1 co‐regulator , 2010, EMBO reports.

[18]  Karen Gelmon,et al.  Metastatic behavior of breast cancer subtypes. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Lluch,et al.  Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research. , 2010, Cancer treatment reviews.

[20]  Da-Qiang Li,et al.  E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1 , 2009, Proceedings of the National Academy of Sciences.

[21]  S. Denslow,et al.  The human Mi-2/NuRD complex and gene regulation , 2007, Oncogene.

[22]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[23]  L. Stephens,et al.  Metastasis Tumor Antigen Family Proteins during Breast Cancer Progression and Metastasis in a Reliable Mouse Model for Human Breast Cancer , 2006, Clinical Cancer Research.

[24]  P. Wade,et al.  Hormonal regulation of metastasis-associated protein 3 transcription in breast cancer cells. , 2004, Molecular endocrinology.

[25]  Carlos S. Moreno,et al.  MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer , 2003, Cell.

[26]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[27]  J. Uitto,et al.  Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3. , 2001, Gene.

[28]  G. Nicolson,et al.  Tumor metastasis‐associated human MTA1 gene: Its deduced protein sequence, localization, and association with breast cancer cell proliferation using antisense phosphorothioate oligonucleotides , 2000, Journal of cellular biochemistry.

[29]  A. Bird,et al.  Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. , 1999, Genes & development.

[30]  Weidong Wang,et al.  NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities. , 1998, Molecular cell.

[31]  G. Nicolson,et al.  A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. , 1994, The Journal of biological chemistry.

[32]  M. Ogawa,et al.  Production of immunoreactive polymorphonuclear leucocyte elastase in human breast cancer cells: possible role of polymorphonuclear leucocyte elastase in the progression of human breast cancer. , 1994, British Journal of Cancer.

[33]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[34]  D. W. Vaughan,et al.  Elastase-like enzymes in human neutrophils localized by ultrastructural cytochemistry , 1980, The Journal of cell biology.

[35]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[36]  Da-Qiang Li,et al.  Unravelling the Complexity and Functions of MTA Coregulators in Human Cancer. , 2015, Advances in cancer research.

[37]  Sandip K. Mishra,et al.  Transcriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor , 2000, Nature Cell Biology.

[38]  Yusuke Nakamura,et al.  Molecular cloning, mapping, and characterization of a novel human gene, MTA1-L1, showing homology to a metastasis-associated gene, MTA1 , 1999, Journal of Human Genetics.